Biotricity (OTCMKTS:BTCY) Issues Quarterly Earnings Results

Biotricity (OTCMKTS:BTCY) announced its quarterly earnings data on Monday. The company reported ($0.49) EPS for the quarter, reports. The company had revenue of $3.20 million for the quarter.

Biotricity Trading Down 12.9 %

Shares of BTCY traded down $0.06 during mid-day trading on Thursday, hitting $0.42. The company’s stock had a trading volume of 48,201 shares, compared to its average volume of 82,018. Biotricity has a 1-year low of $0.37 and a 1-year high of $2.43. The firm has a market capitalization of $9.05 million, a P/E ratio of -0.32 and a beta of 1.39. The firm has a 50-day simple moving average of $0.73 and a 200 day simple moving average of $1.02.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.